Executive Insights: Drugs and Money in a Time of Change

Join us for discussions and presentations on healthcare development in an unpredictable market.

This forum is by-invitation and will provide insights from growing companies, investors, capital and strategic advisors on how to navigate an increasingly complex global market and bring new treatments to the clinic and the market in Sweden, the US and around the world. A day of knowledge, creativity, new ideas and networking! 

Sign up through the button and scroll down to view the agenda. The event will be in Swedish with some parts in English.

See you on the 9th of April!

Cytel, DNB//Back Bay, Flerie and Linc

Agenda

09:30

Registration, coffee and sandwich

10:00

Welcome remarks

10:10

Decision-making in a fast-changing world

Moderator: Anna Törner (Cytel)

Read more
Mona Riabacke
Key Note Speaker
Jakob Lindberg
CSO, Oncopeptides
11:00

Networking break with coffee

11:20

How to capture investor attention in the capital market

Hosted by DNB//Back Bay

Moderator:
Karl Tobieson (Linc)

Read more
Jonathan P. Gertler
Founder, Managing Partner, Back Bay Life Science Advisors
Greg Benning
Partner, Managing Director, Back Bay Life Science Advisors
Benedicte Kilander Bakke
Fund Manager, DNB
Patrik Ling
Analyst, DNB
Mårten Steen
Managing Partner, HealthCap
12:15

LUNCH

13:15

The secret of successful cooperations

Moderator: Maria Lundberg (Cytel)

Read more
Lars-Johan Åge
Key Note Speaker
14:15

Short stand-up: meet your neighbor!

14:30

Critical building blocks for successful deals and partnering

Moderator: Karl Tobieson (Linc)

Read more
Ted Fjällman
CEO, Flerie
Gunilla Osswald
CEO, BioArctic
15:30

Networking break with fika

16:00

Overcoming challenges when reaching for the stars

Moderator: Anna Törner (Cytel)

Read more
Pia Baumann
CMO, Medivir
Marika Nestor
CEO, Akiram
Alexandra Ekman Ryding
CEO, Atrogi
Eva-Karin Gidlund
CBO, NorthX Biologics
17:00

Closing remarks, wine reception and networking

Speakers

Mona Riabacke
Key Note Speaker

Lars-Johan Åge
Key Note Speaker

Gunilla Osswald
CEO, BioArctic

Jakob Lindberg
CSO, Oncopeptides

Marika Nestor
CEO, Akiram

Alexandra Ekman Ryding
CEO, Atrogi

Pia Baumann
CMO, Medivir

Eva-Karin Gidlund
CBO, NorthX Biologics

Ted Fjällman
CEO, Flerie

Benedicte Kilander Bakke
Fund Manager, DNB

Patrik Ling
Analyst, DNB

Jonathan P. Gertler
Founder, Managing Partner, Back Bay Life Science Advisors

Greg Benning
Partner, Managing Director, Back Bay Life Science Advisors

Mårten Steen
Managing Partner, HealthCap